A Population Pharmacokinetic (Pk)- Pharmacodynamic (Pd) Analysis Of Peginesatide India Lysis Patients With Chronic Kidney Disease

Peginesatide is an erythropoiesis stimulating agent (ESA) being developed for the treatment of anemia due to chronic kidney disease in dialysis patients. The purpose of this analysis was to develop a population PK-PD model to characterize time-course of peginesatide plasma and hemoglobin (Hb) concen...

Full description

Saved in:
Bibliographic Details
Published inKidney research and clinical practice Vol. 31; no. 2; p. A60
Main Authors Naik, Himanshu, Tsai, Max, Qiu, Ping, Vakilynejad, Majid
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.06.2012
The Korean Society of Nephrology
Subjects
Nephrology
Online AccessGet full text

Cover

Be the first to leave a comment!
You must be logged in first